{
  "id": "cluster_17_doc3",
  "content": "Research summary from Emerging Tech pilot: 32% of participants in genetic testing program demonstrated clinically actionable variants identified through expanded panel testing versus standard single-gene approaches. Notable finding: Younger cohort (38-45) showed higher rates of variant interpretation changes compared to older participants. Program utilization highest at Templeton Cancer Center and affiliate clinics. Interim reimbursement rates set at $1,250 per full panel.",
  "metadata": {
    "format": "research_note"
  }
}